Keio University

Press Release

61-70 items (total 448)
Published At March 29, 2024

Application for Marketing Approval of Japan's First Gene Panel Test for Hematologic Malignancies

Published At March 29, 2024

Characteristics of Ku Antibody-Positive Myositis Revealed

Published At March 13, 2024

Data Science Elucidates the Mechanism of Nerve Regeneration Through Gene Expression Regulation by Hepatocyte Growth Factor (HGF) in Spinal Cord Injury Tissue

Published At March 11, 2024

Utilizing Patient-Reported Outcomes to Bridge the Communication Gap Between Physicians and Patients—Enabling Treatment Proposals More Aligned with Patient Needs—

Published At February 28, 2024

Discovery of the Most Significant Pathogenic Genetic Variant for Severe Congenital Heart Disease (Truncus Arteriosus) in Japanese Individuals

Published At February 22, 2024

Discovery of a Gene Involved in Scleral Deformation during Myopia Progression—Scleral Remodeling by Thrombospondin-1—

Published At February 22, 2024

Discovery of a Mechanism Causing Drug Resistance in Breast Cancer: Metabolic Pathway Switching via Methylation of Multiple Glycolytic Enzymes Identified as a Key Factor—Paving the Way for New Therapeutic Targets Based on Metabolic Properties

Published At February 20, 2024

Evaluation of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Can Be Conducted via Online Consultations—Verifying the High Reliability of Remote ADHD Assessment—

Published At February 14, 2024

2022 Change in Aggregation Method Found to Decrease Cases of Suicide with Unknown Reasons and Increase Cases with Identified Reasons—Offering New Insights into Understanding the Reasons for Modern Suicides

Published At February 09, 2024

Investigator-Initiated Clinical Trial Demonstrates Efficacy of Anti-PD-1 Antibody Therapy for Unresectable Advanced or Recurrent Epithelial Skin Cancer—Partial Change to Manufacturing and Marketing Approval Obtained in Japan for OPDIVO® Intravenous Infusion—